Skip to content

News -

BI tool for smooth submission planning and execution

Regulatory approval for pharmaceutical products can be difficult to obtain, not least because the submission process is often slow and prone to errors. Thomas Svendsen and Peter Noes of NNIT tell World Pharmaceutical Frontiers how regulatory teams can use a business intelligence tool to monitor submission status and hasten time to market. 

For many pharmaceutical companies, the process of regulatory submission is fraught with setbacks. Faced with a mass of data and no standardised means of tracking it, they are forced to use Excel or even Word-based tools to help prepare and finalise their submissions. And, because this work is performed manually, there is always the risk of making errors along the way. 

"Before you actually make the submission, it’s quite difficult to get it all assembled and ensure that documents are signed and approved," says Thomas Svendsen, principal consultant at NNIT. "There are no standard systems as we know it, and we haven’t seen any that are able to track it convincingly." 

For a smaller project this may not pose much of an issue but, when companies are dealing with a larger electronic common technical document (eCTD) submission, matters become more complex. It is not unusual to reach the end of the process and discover that certain documents haven’t been signed or even that they’ve been misplaced. This can lead to delays, which may affect time to market and damage the bottom line.

 


Related links

Topics

Contacts

Tina Joanne Hindsbo

Tina Joanne Hindsbo

Press contact Head of Public & Media Relations +45 3077 9578
Sofie Mand Steffens

Sofie Mand Steffens

Press contact Senior Communications Consultant +45 3077 8337

Related content

Are you ready for ISO IDMP?

Are you ready for ISO IDMP?

Following the implementation of XEVMPD, new legislation, based on five new ISO IDMP standards, is due to come into force in 2016. Rune Ringsholm Bergendorff, advanced business consultant at NNIT, explains how pharmaceutical companies will need to adapt business processes across the whole organisation.

Global Tracking Regulations Present Challenges and Benefits

Drug makers are facing an ever-increasing challenge as more countries implement serialization and tracking regulations and set compliance deadlines in an effort to ensure the safety and quality of prescription drugs being sold within their borders. Complying with regulations coming into effect will be a demanding task due to a lack of global harmonization.

ISO IDMP is the next after xEVMPD

ISO IDMP is the next wave in the pharmacovigilance legislation after xEVMPD. But with a global scope and requiring data integration from the entire company it is a much bigger wave. ISO IDMP will transform your regulatory IT strategy.

Make the most of serialization

Change is afoot for pharmaceutical companies, with new serialisation legislation on the agenda. To help stem the problem of drug counterfeiting, they will be required to adopt a unique serial number labelling system and adapt their business processes accordingly. How can companies derive real business value from the investments they are now required to make?

PSMF establishment and maintenance, business as usual?

Since the implementation of Directive 2010/84 and Regulation 1235/2010, marketing authorisation holders (MAHs) with products on the European market are obliged to maintain, and make available upon request, a Pharmacovigilance System Master File (PSMF).